- Home
- STRO vs PTLO Comparison
STRO vs PTLO Comparison
Compare STRO & PTLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | STRO | PTLO |
|---|---|---|
| Founded | 2003 | 1963 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Restaurants |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 332.8M | 326.3M |
| IPO Year | 2018 | 2021 |
Fundamental Metrics
Financial Performance| Metric | STRO | PTLO |
|---|---|---|
| Price | $16.69 | $4.10 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 9 | 11 |
| Target Price | ★ $31.33 | $8.06 |
| AVG Volume (30 Days) | 263.7K | ★ 1.2M |
| Earning Date | 05-11-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.09 |
| Revenue | $38,419,000.00 | ★ $732,066,000.00 |
| Revenue This Year | N/A | $9.02 |
| Revenue Next Year | N/A | $5.81 |
| P/E Ratio | ★ N/A | $45.67 |
| Revenue Growth | N/A | ★ 3.03 |
| 52 Week Low | $0.72 | $3.78 |
| 52 Week High | $43.85 | $6.83 |
Technical Indicators
Market Signals| Indicator | STRO | PTLO |
|---|---|---|
| Relative Strength Index (RSI) | 27.91 | 36.81 |
| Support Level | $10.34 | $3.79 |
| Resistance Level | $26.35 | $4.49 |
| Average True Range (ATR) | 1.05 | 0.19 |
| MACD | -0.14 | -0.07 |
| Stochastic Oscillator | 4.21 | 6.64 |
Price Performance
Historical ComparisonAbout STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. Company's wholly-owned product candidate is STRO-004, a single homogeneous ADC directed against tissue factor which are developing for the treatment of solid tumors. The company also pipeline contains STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.
About PTLO Portillo's Inc.
Portillos Inc serves the Chicago street food industry through high-energy and multichannel restaurants designed to ignite the senses and create memorable dining experiences. The company owns and operates fast-casual restaurants in the United States, along with two food production commissaries in Illinois. Its menu includes hot dogs, beef and sausage sandwiches, sandwiches and ribs, salads, burgers, chicken, sides and soup, and others.